A phase IIA, randomised, double-blind, double-dummy, placebo and active comparator controlled, 5-way crossover clinical trial to assess the activity, safety, tolerability and pharmacokinetics of single doses of LAS 100977 administered by inhalation to asthma patients.

Trial Profile

A phase IIA, randomised, double-blind, double-dummy, placebo and active comparator controlled, 5-way crossover clinical trial to assess the activity, safety, tolerability and pharmacokinetics of single doses of LAS 100977 administered by inhalation to asthma patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2014

At a glance

  • Drugs Abediterol; Salmeterol
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Almirall S.A.
  • Most Recent Events

    • 02 Jun 2012 Actual end date (19 Feb 2008) added as reported by European Clinical Trials Database.
    • 01 May 2012 Official title amended as reported by European Clinical Trials Database.
    • 01 May 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2007-003415-31).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top